Multi-omics analysis of epigenetic dysregulation reveals clinical heterogeneity and evaluates the immunotherapeutic potential of lung adenocarcinoma.

ABSTRACT:

SUBMITTER: Ren Y 

PROVIDER: S-EPMC12166690 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature